Renovacor Stock Price, News & Analysis
Company Description
Renovacor (NYSE: RCOR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $55.3M.
RCOR stock has declined 63.6% over the past year.
This page provides a comprehensive overview of RCOR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Renovacor (RCOR) stock. Over the past 12 months, the stock has lost 63.6%. At a market capitalization of $55.3M, RCOR is classified as a micro-cap stock with approximately 17.3M shares outstanding.
Latest News
Renovacor has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include management, acquisition, conferences, earnings. View all RCOR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
RCOR Company Profile & Sector Positioning
Renovacor (RCOR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NYSE.
Investors comparing RCOR often look at related companies in the same sector, including Karyopharm Therapeutics Inc (KPTI), Liminatus Pharma (LIMN), Sigilon Therapeutics, Inc. (SGTX), MAIA Biotechnology Inc. (MAIA), and Camp4 Therapeutics Corp. (CAMP). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate RCOR's relative position within its industry.